AI assistant
CONAGRA BRANDS INC. — Director's Dealing 2017
Dec 1, 2017
30694_dirs_2017-12-01_01917766-5687-4bfc-9bdb-3d7f084763a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONAGRA BRANDS INC. (CAG)
CIK: 0000023217
Period of Report: 2017-11-29
Reporting Person: Batcheler Colleen (EVP Gen Counsel & Corp Secty)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-29 | Common Stock | M | 48369 | $18.42 | Acquired | 211514 | Direct |
| 2017-11-29 | Common Stock | M | 72082 | $23.00 | Acquired | 283596 | Direct |
| 2017-11-29 | Common Stock | S | 120451 | $37.50 | Disposed | 163145 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-11-29 | Employee Stock Options (right to buy) | $18.42 | M | 48369 | Disposed | 2022-07-16 | Common Stock (48369) | Direct |
| 2017-11-29 | Employee Stock Options (right to buy) | $23.00 | M | 72082 | Disposed | 2024-07-13 | Common Stock (72082) | Direct |
Footnotes
F1: Shares sold pursuant to a predefined Rule 10b5-1 trading plan.
F2: All of the shares being sold were acquired by the Reporting Person within the past two business days upon the exercise of stock options.
F3: Reflects an antidilution adjustment to the number of options (originally granted on July 16, 2012 and expiring July 16, 2022, for 120,000 shares at an exercise price of $24.74 per share) held by the Reporting Person and the exercise price thereof, which antidilution adjustment was made prior to the exercise date in connection with the spinoff of Lamb Weston Holdings, Inc. from the Issuer on November 9, 2016 (the "Spinoff").
F4: These stock options, which covered 48,369 shares immediately following the Spinoff, became exercisable as to 40% on July 16, 2013, 30% on July 16, 2014, and 30% on July 16, 2015.
F5: Reflects an antidilution adjustment to the number of options (originally granted on July 14, 2014 and expiring July 13, 2024, for 153,285 shares at an exercise price of $30.89 per share) held by the Reporting Person and the exercise price thereof, which antidilution adjustment was made prior to the exercise date in connection with the Spinoff.
F6: These stock options, which covered 205,951 shares immediately following the Spinoff, became exercisable as to 40% on July 14, 2015, 30% on July 14, 2016, and 30% on July 14, 2017.